完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | 賀鈺 | zh_TW |
dc.contributor.author | 趙瑞益 | zh_TW |
dc.contributor.author | HO, YU | en_US |
dc.contributor.author | Chao, Jui-I | en_US |
dc.date.accessioned | 2018-01-24T07:42:43Z | - |
dc.date.available | 2018-01-24T07:42:43Z | - |
dc.date.issued | 2017 | en_US |
dc.identifier.uri | http://etd.lib.nctu.edu.tw/cdrfb3/record/nctu/#GT070457045 | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/142843 | - |
dc.language.iso | zh_TW | en_US |
dc.subject | 三陰性乳癌 | zh_TW |
dc.subject | 奈米鑽石 | zh_TW |
dc.subject | 紫杉醇 | zh_TW |
dc.subject | 表皮生長因子受體 | zh_TW |
dc.subject | 標靶治療 | zh_TW |
dc.subject | Triple negative breast cancer | en_US |
dc.subject | Epidermal growth factor receptor | en_US |
dc.subject | Nanodiamond | en_US |
dc.subject | Paclitaxel | en_US |
dc.subject | Cetuximab | en_US |
dc.title | 利用新穎奈米鑽石藥物複合體在人類三陰性乳癌細胞之表皮生長因子受體的標靶治療 | zh_TW |
dc.title | Targeting therapy on the EGFR using novel nanodiamond-drug composites in human triple negative breast cancer | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | 生物科技學系 | zh_TW |
顯示於類別: | 畢業論文 |